Flying The Web For News.
  • 2024 Presidential Election
    2024 Presidential Election
  • Career Exam Study
    Career Exam Study
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service

Press Release: Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles

Details
Category: Globe NewsWire News Distribution Service

Hamilton, Bermuda, July 19, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq:CYTO), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today announced the preprint publication of a  study demonstrating effective treatment of abdominal aortic aneurysm (AAA) in an animal model.1 The study was conducted…


Posted: 2024-07-19 13:01:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.

Tags

press | release | altamira | therapeutics | announces


Related News Stories From The Web And More

Related Bing News Search Results

Press Release: Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles - Newscast

Arialys Therapeutics Announces First Participants Dosed in a Phase 1 Clinical Trial of ART5803, a Precision Medicine for the Treatment of Autoimmune Neuropsychiatric Diseases

Thu, 10 Oct 2024 02:00:00 GMT LA JOLLA, Calif.--(BUSINESS WIRE)--Arialys Therapeutics, a clinical-stage biotechnology company pioneering new precision medicines for autoimmune neuropsychiatry, today announced that it has ...

Appili Therapeutics – Press Release Correction

Wed, 09 Oct 2024 17:01:00 GMT HALIFAX, Nova Scotia, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), announces correction to its press release entitled ...

Altamira Therapeutics Provides Update on Nasdaq Listing

Mon, 07 Oct 2024 13:41:00 GMT Altamira Therapeutics Ltd. (“Altamira” or the ... or that any extension will be granted by the Panel. This press release contains “forward-looking statements” within the meaning of ...

Barbie announces first "Diwali doll" ahead of festival of lights

Sat, 05 Oct 2024 10:35:00 GMT Lalit Agarwal, country manager for Mattel India, said in a news release that through the Diwali doll, the brand is hoping to showcase "India's vibrant cultural heritage on a global stage while ...

Altamira Therapeutics faces Nasdaq delisting over share price

Fri, 04 Oct 2024 13:14:00 GMT The information in this article is based on a press release statement from Altamira Therapeutics Ltd. In other recent news, Altamira Therapeutics and its associate company, Altamira Medica ...


Blow Us A Whistle